Listar por tema "drug structure"

Ordenar por:Orden:Resultados:

  • Ruiz, C.; Haddad, M.; Alban, J.; Bourdy, G.; Reategui, R.; Castillo Pareja, Denis Helan; Sauvain, Michel Henri Auguste; Deharo, E.; Estevez, Y.; Arévalo Zelada, Jorge Luis; Rojas, R. (Elsevier, 2011)
    The bioassay-guided purification of the ethanolic extract from the leaves of Piper hispidum led to the isolation of one new amide, N-2-(3′,4′, 5′-trimethoxyphenyl)ethyl-2-hydroxybenzamide (1) as well as two known chalcones ...
  • Hernández-Vásquez, A.; Alarcon-Ruiz, C.A.; Bendezu-Quispe, G.; Comandé, D.; Rosselli, D. (BioMed Central, 2018)
    Background: Biosimilars could be a promising option to help decrease healthcare costs and expand access to treatment. There is no previous evidence of a global bibliometric analysis on biosimilars. Therefore, we aimed to ...
  • Gonzalez Zariquiey, Armando Emiliano; Codd, Ellen E.; Horton, John; García Lescano, Héctor Hugo; Gilman, Robert Hugh (Taylor and Francis, 2018)
    Introduction: Oxfendazole (methyl [5-(phenylsulphinyl)-1H benzimidazole-2-yl] carbamate) has a particularly long metabolic half-life in ruminants, and its metabolite fenbendazole also has anthelminthic action. A very limited ...

Buscar en el Repositorio

Listar

Panel de Control